According to Mesoblast 's latest financial reports the company's current EPS (TTM) is HK$312.31. In 2022 the company made an earnings per share (EPS) of HK$283.21 an increase over its 2021 EPS that were of -HK$5.90.
Year | EPS | Change |
---|---|---|
2023 (TTM) | HK$315.83 | 11.52% |
2022 | HK$283.21 | -4897.44% |
2021 | -HK$5.90 | -13.08% |
2020 | -HK$6.79 | 17.91% |
2019 | -HK$5.76 | -17.18% |
2018 | -HK$6.95 | 141.13% |
2017 | -HK$2.88 | 422.52% |
2016 | -HK$0.55 | -94.58% |
2015 | -HK$10.19 |